Advanced Enzyme Technologies Limited (ADVENZYMES) - Total Liabilities
Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has total liabilities worth Rs1.58 Billion INR (≈ $17.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ADVENZYMES cash flow conversion to assess how effectively this company generates cash.
Advanced Enzyme Technologies Limited - Total Liabilities Trend (2008–2025)
This chart illustrates how Advanced Enzyme Technologies Limited's total liabilities have evolved over time, based on quarterly financial data. Check Advanced Enzyme Technologies Limited (ADVENZYMES) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Advanced Enzyme Technologies Limited Competitors by Total Liabilities
The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Wanfeng Chemical Co. Ltd. A
SHG:603172
|
China | CN¥391.97 Million |
|
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
|
USA | $23.01 Million |
|
Poongsan Holdi
KO:005810
|
Korea | ₩203.01 Billion |
|
DBV Technologies S.A.
PA:DBV
|
France | €57.64 Million |
|
Suzhou Harmontronics Auto Tech Co Ltd
SHG:688022
|
China | CN¥1.87 Billion |
|
The York Water Company
NASDAQ:YORW
|
USA | $429.04 Million |
|
Concord Securities Co Ltd
TWO:6016
|
Taiwan | NT$38.05 Billion |
|
MediaAlpha Inc.
NYSE:MAX
|
USA | $332.01 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Advanced Enzyme Technologies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ADVENZYMES market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.72 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Advanced Enzyme Technologies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Advanced Enzyme Technologies Limited (2008–2025)
The table below shows the annual total liabilities of Advanced Enzyme Technologies Limited from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs1.53 Billion ≈ $16.51 Million |
-7.12% |
| 2024-03-31 | Rs1.64 Billion ≈ $17.78 Million |
+19.40% |
| 2023-03-31 | Rs1.38 Billion ≈ $14.89 Million |
+8.22% |
| 2022-03-31 | Rs1.27 Billion ≈ $13.76 Million |
+4.36% |
| 2021-03-31 | Rs1.22 Billion ≈ $13.18 Million |
+9.67% |
| 2020-03-31 | Rs1.11 Billion ≈ $12.02 Million |
+4.58% |
| 2019-03-31 | Rs1.06 Billion ≈ $11.49 Million |
-29.13% |
| 2018-03-31 | Rs1.50 Billion ≈ $16.22 Million |
+44.13% |
| 2017-03-31 | Rs1.04 Billion ≈ $11.25 Million |
-37.73% |
| 2016-03-31 | Rs1.67 Billion ≈ $18.07 Million |
-16.24% |
| 2015-03-31 | Rs1.99 Billion ≈ $21.57 Million |
-15.12% |
| 2014-03-31 | Rs2.35 Billion ≈ $25.42 Million |
+2.14% |
| 2013-03-31 | Rs2.30 Billion ≈ $24.88 Million |
-8.30% |
| 2012-03-31 | Rs2.51 Billion ≈ $27.14 Million |
+180.57% |
| 2011-03-31 | Rs894.39 Million ≈ $9.67 Million |
+48.72% |
| 2010-03-31 | Rs601.38 Million ≈ $6.50 Million |
+7.27% |
| 2009-03-31 | Rs560.60 Million ≈ $6.06 Million |
-4.56% |
| 2008-03-31 | Rs587.36 Million ≈ $6.35 Million |
-- |
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more